1. Home
  2. ABVX vs GCI Comparison

ABVX vs GCI Comparison

Compare ABVX & GCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • GCI
  • Stock Information
  • Founded
  • ABVX 2013
  • GCI 1997
  • Country
  • ABVX France
  • GCI United States
  • Employees
  • ABVX N/A
  • GCI N/A
  • Industry
  • ABVX
  • GCI Newspapers/Magazines
  • Sector
  • ABVX
  • GCI Consumer Discretionary
  • Exchange
  • ABVX Nasdaq
  • GCI Nasdaq
  • Market Cap
  • ABVX 722.3M
  • GCI 734.1M
  • IPO Year
  • ABVX N/A
  • GCI N/A
  • Fundamental
  • Price
  • ABVX $6.16
  • GCI $4.97
  • Analyst Decision
  • ABVX Strong Buy
  • GCI Buy
  • Analyst Count
  • ABVX 7
  • GCI 2
  • Target Price
  • ABVX $37.86
  • GCI $5.55
  • AVG Volume (30 Days)
  • ABVX 216.6K
  • GCI 933.7K
  • Earning Date
  • ABVX 09-09-2024
  • GCI 02-20-2025
  • Dividend Yield
  • ABVX N/A
  • GCI N/A
  • EPS Growth
  • ABVX N/A
  • GCI N/A
  • EPS
  • ABVX N/A
  • GCI N/A
  • Revenue
  • ABVX $9,676,417.00
  • GCI $2,557,445,000.00
  • Revenue This Year
  • ABVX $31.67
  • GCI N/A
  • Revenue Next Year
  • ABVX $759.77
  • GCI N/A
  • P/E Ratio
  • ABVX N/A
  • GCI N/A
  • Revenue Growth
  • ABVX 100.87
  • GCI N/A
  • 52 Week Low
  • ABVX $5.54
  • GCI $1.95
  • 52 Week High
  • ABVX $17.02
  • GCI $5.93
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 30.30
  • GCI 45.43
  • Support Level
  • ABVX $5.54
  • GCI $4.86
  • Resistance Level
  • ABVX $6.46
  • GCI $5.21
  • Average True Range (ATR)
  • ABVX 0.51
  • GCI 0.22
  • MACD
  • ABVX -0.04
  • GCI -0.00
  • Stochastic Oscillator
  • ABVX 30.10
  • GCI 28.57

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

About GCI Gannett Co. Inc.

Gannett Co Inc is a digital newspaper company providing local media and marketing solutions in the U.S. The group operates in three segments, Domestic Gannett Media, Newsquest, and Digital Marketing Solutions. The majority of revenue is from the Domestic Gannett Media segment. The company's brands include USA TODAY and more than 250 daily newspapers as well as digital marketing services companies, including ReachLocal, WordStream, and others. The company produces more than 350 annual events, such as themed expos. The company also operates in the U.K. through the U.K. media company Newsquest, providing more than 150 local media brands.

Share on Social Networks: